Center for Financial Planning’s Fulgent Genetics FLGT Stock Holding History

Center for Financial Planning’s Portfolio FLGT Stock Details FLGT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$318	Hold	20	–	–	﹤0.01%	625
2025 Q4	$526	Hold	20	–	–	﹤0.01%	650
2025 Q3	$452	Hold	20	–	–	﹤0.01%	629
2025 Q2	$398	Hold	20	–	–	﹤0.01%	616
2025 Q1	$338	Hold	20	–	–	﹤0.01%	675
2024 Q4	$370	Hold	20	–	–	﹤0.01%	641
2024 Q3	$435	Hold	20	–	–	﹤0.01%	542
2024 Q2	$393	Hold	20	–	–	﹤0.01%	555
2024 Q1	$434	Hold	20	–	–	﹤0.01%	583
2023 Q4	$579	Hold	20	–	–	﹤0.01%	501
2023 Q3	$535	Hold	20	–	–	﹤0.01%	494
2023 Q2	$741	Hold	20	–	–	﹤0.01%	531
2023 Q1	$625	Hold	20	–	–	﹤0.01%	495
2022 Q4	$596	Hold	20	–	–	﹤0.01%	499
2022 Q3	$1K	Hold	20	–	–	﹤0.01%	592
2022 Q2	$1K	Hold	20	–	–	﹤0.01%	498
2022 Q1	$1K	Hold	20	–	–	﹤0.01%	500
2021 Q4	$2K	Hold	20	–	–	﹤0.01%	480
2021 Q3	$2K	Hold	20	–	–	﹤0.01%	454
2021 Q2	$2K	Hold	20	–	–	﹤0.01%	458
2021 Q1	$2K	Buy	+20	New	+$2.06K	﹤0.01%	490

Other funds holding FLGT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

ICM

Invenomic Capital Management Boston, Massachusetts $2.18B AUM 0.03% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Center for Financial Planning's FLGT Position: Q1 2026 in Review

Center for Financial Planning held its Fulgent Genetics (FLGT) position steady in Q1 2026 at 20 shares worth $318. The position accounts for ﹤0.01% of the portfolio, ranked #625.

Center for Financial Planning first reported a position in FLGT in Q1 2021 and has held it in 21 quarters since. The position peaked at $2K in Q4 2021. 157 funds tracked by Wall St. Rank hold FLGT as of Q1 2026.

Center for Financial Planning held 20 shares of Fulgent Genetics worth $318 as of Q1 2026.
Center for Financial Planning left its Fulgent Genetics share count unchanged in Q1 2026.
Fulgent Genetics made up ﹤0.01% of Center for Financial Planning's portfolio in Q1 2026, its #625 holding.
Center for Financial Planning first reported a position in Fulgent Genetics in Q1 2021 and has held it in 21 quarters since.
Center for Financial Planning's Fulgent Genetics position peaked at $2K in Q4 2021.
157 funds tracked by Wall St. Rank held Fulgent Genetics as of Q1 2026.

Based on Center for Financial Planning's 13F filing for Q1 2026, filed 4 May 2026.